Author:
Sayaka Ban (JP)
Abstract:
Objectives: MALDI offers a cost-effective and time-saving solution for clinical laboratory identification, alternative to sequencing. Fungal identification, however, faces challenges due to limited references compared to bacteria. For address this, we have previously constructed a library using supervised machine learning for Aspergillus section Nigri, a discriminative model for identifying drug-resistant strains of A. fumigatus, and a main spectral profiles library containing a wide range of species. Here, we presented the evaluation results of the three resources.
Methods: A collaborative project among the three microbe culture collections has resulted in the development EMALiMB: an extended database for rapid identification by the Biotyper (Bruker). The library includes a total of 633 species from 153 genera of fungi, 1,709 MSPs. For section Nigri, SARAMIS (bioMérieux) was used for discrimination among species. We also created a model for identification azole resistant A. fumigatus strains by discriminative methods and multivariate analysis (eMSTAT, Shimadzu). Validation test was conducted by using novel isolates, respectively.
Results: The European reference had previously resulted in lower scores for isolates from Japan, but they improved by add-on EMALiMB, especially for non-albicans species. This unsupervised machine learning library effectively distinguished closely related species within Aspergillus section Fumigati, but not within section Nigri. With the supervised machine learning library, it was possible to differentiate closely related species such as between A. tubingensis and A. neoniger. However, it struggled with A. welwitschiae from A. niger s.s. as shown by genomic analyses in the previous study (Bian et al. 2022, Stud Mycol). This system can accommodate a wide range of fungal species but may require redesigning from scratch due to enhancing the evaluation of species-specific peaks, when changes occur in the classification system or new species emerge. The discriminative model for azole-resistant A. fumigatus was achieving a 97.06% accuracy rate in VITEK MS and 92.5% in Biotyper for clinical isolates. However, false positives were frequent in isolates from tulip bulb (TR variant), suggested that this discriminative model might reflect regional characteristics rather than resistant characteristics.
Conclusions: These MALDI resources will significantly improve rapid clinical identification, though they may need adjustments to libraries and models to align with specific applications.
Abstract Number: 26
Conference Year: 2024
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a